These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 25634751

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.
    Voss SM, Riley MP, Lokhandwala PM, Wang M, Yang Z.
    Am J Surg Pathol; 2015 Jan; 39(1):13-24. PubMed ID: 25353284
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tumour budding is a strong and independent prognostic factor in pancreatic cancer.
    Karamitopoulou E, Zlobec I, Born D, Kondi-Pafiti A, Lykoudis P, Mellou A, Gennatas K, Gloor B, Lugli A.
    Eur J Cancer; 2013 Mar; 49(5):1032-9. PubMed ID: 23177090
    [Abstract] [Full Text] [Related]

  • 5. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
    Ye HL, Li DD, Lin Q, Zhou Y, Zhou QB, Zeng B, Fu ZQ, Gao WC, Liu YM, Chen RW, Li ZH, Chen RF.
    World J Gastroenterol; 2015 Jun 07; 21(21):6621-30. PubMed ID: 26074700
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers.
    La Rosa S, Adsay V, Albarello L, Asioli S, Casnedi S, Franzi F, Marando A, Notohara K, Sessa F, Vanoli A, Zhang L, Capella C.
    Am J Surg Pathol; 2012 Dec 07; 36(12):1782-95. PubMed ID: 23026929
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas.
    Thies S, Guldener L, Slotta-Huspenina J, Zlobec I, Koelzer VH, Lugli A, Kröll D, Seiler CA, Feith M, Langer R.
    Hum Pathol; 2016 Jun 07; 52():1-8. PubMed ID: 26980046
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation.
    Lüttges J, Schemm S, Vogel I, Hedderich J, Kremer B, Klöppel G.
    J Pathol; 2000 Jun 07; 191(2):154-61. PubMed ID: 10861575
    [Abstract] [Full Text] [Related]

  • 16. Differential expression of STAT1 and p21 proteins predicts pancreatic cancer progression and prognosis.
    Sun Y, Yang S, Sun N, Chen J.
    Pancreas; 2014 May 07; 43(4):619-23. PubMed ID: 24658320
    [Abstract] [Full Text] [Related]

  • 17. Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system.
    Karamitopoulou E, Wartenberg M, Zlobec I, Cibin S, Worni M, Gloor B, Lugli A.
    Histopathology; 2018 Jul 07; 73(1):137-146. PubMed ID: 29495092
    [Abstract] [Full Text] [Related]

  • 18. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A, Xu Y, Liu S, Jin T, Li Z, Jin H, Lin L, Lin Z.
    Exp Mol Pathol; 2014 Feb 07; 96(1):54-60. PubMed ID: 24263054
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.